Gynaecological Oncology Unit Lead

Size: px
Start display at page:

Download "Gynaecological Oncology Unit Lead"

Transcription

1 Learning Outcomes: Gynaecological Oncology Unit Lead To develop knowledge and skills required by an individual to undertake the role as the Gynaecologial Oncology Unit Lead. Gynaecological Cancers Knowledge Criteria Clinical Competency to be achieved Professional Skills and Attitudes Training support Evidence/ Assessment Broad knowledge of aetiology and differential diagnosis of vulval, cervical, endometrial and ovarian cancer carcinoma Understanding of risk factors for developing vulval,,cervical endometrial and ovarian cancer Understanding diagnostic tests, investigations and staging procedures Understanding genetic predisposition to disease and the role of prophylactic surgery and screening Clinical evaluation of patients with gynaecological cancers Ability to distinguish gynaecological cancers from other malignancies Ability to counsel patients about gynaecological malignancies their treatment and prognosis. Undertake required diagnostic procedures and interpret the results Undertake clinical staging for cervical, vulval and endometrial cancers. Undertake surgical intervention for early stage endometrial cancer [ in patient cohorts identified in National Cancer Plan] Managing Rapid Access pathways for suspected gynaecological cancers. Awareness of psychological and emotional implications for patient and family and staff Realistic recognition of own competence level Use of appropriate external protocols and guidelines Making appropriate tertiary referrals Chairing MDT meetings, and teleconferencing or equivalent with Cancer Centre Attendance of RCOG and other courses relevant to the subject Attendance at MDT and Regional Network Meetings Local/regional protocols Useful Websites dance/healthandsocialcare Topics/Cancer/fs/en Case Log book CbDs Audit projects Certificates of course attendance MDT Attendance Attendance at relevant National Meetings Team observation

2 Understanding of trophoblastic disease Knowledge of options for treatment and likely outcocmes Knowledge about chemotherapy, radiotherapy and hormonal treatment in gynaecological cancers. Knowledge of recent clinical trials and peer reviewed data Awareness of patient pathways, and referrals mechanism to the Cancer Centre. Ability to discuss different modalities of treatment confidently and advise patients appropriately Ability to inform and counsel patients about clinical trials for treatment options Collaboration with consultant colleagues and colleagues in other specialities and departments Recognition of dynamics of consultation after bad news and ability to iffer patients time and support to make decisions Courses in Counselling Genetic counselling training opportunities through local network or PG courses Knowledge of rare cancers vaginal/fallopian tube Knowledge of patterns of disease relapse Knowledge of palliative care aspects of management

3 Section 1 VULVAL CANCER Skill ATM: Gynaecological Cancer Unit Lead Observation Direct Supervision Independent Practice Date Signature Date Signature Date Signature Examination of Vulva ( colposcopy) Excisional biopsy of vulval lesion Tumour Staging [Clinical] Patient counselling Patient Referral Radical Vulval cancer surgery

4 Section 2 CERVICAL CANCER Skill ATM: Gynaecological Cancer Unit Lead Observation Direct Supervision Independent Practice Date Signature Date Signature Date Signature Examination of the cervix (colposcopy) Diagnosis of Cervical Carcinoma Biopsy of Tumour Tumour Staging Patient Counselling Patient Referral Observation of Wertheim s Hysterectomy

5 Section 3 ENDOMETRIAL CANCER Skill ATM: Gynaecological Cancer Unit Lead Observation Direct Supervision Independent Practice Date Signature Date Signature Date Signature Assessment of PMB Diagnosis of Endometrial Carcinoma Endometrial Sampling Tumour Staging Patient counselling Patient Referral Surgical Management of Endometrial Cancer

6 Section 4 OVARIAN CANCER Skill ATM: Gynaecological Cancer Unit Lead Observation Direct Supervision Independent Practice Date Signature Date Signature Date Signature Assessment of Possible Ovarian Cancer Use of Risk of Malignancy Index Ascitic Fluid Tap/Paracentesis Patient Counselling on genetic risk/screening Patient counselling on disease and therapy Patient Referral Observation of Ovarian Cancer Surgery

7 Training Courses or sessions Title Signature of educational supervisor Date Authorisation of Signatures please print your name and sign below Name (please print) Signature Completion of Module I confirm that all components of the module have been successfully completed Date Name of Educational Superviser Signature of Educational Superviser

8 APPENDIX TO GYNAECOLOGICAL ONCOLOGY UNIT LEAD Details of knowledge criteria Broad knowledge of aetiology and risk factors for gynaecological cancers VIN,CIN,BRCA1/2 genes, HNPPC, HPV 16,18,Obesity,Diabetes, Tamoxifen. Relationship with other cancers: i.e. Breast Cancer,Colon Cancers. Family history and risk. Extensive knowledge of Investigations in Gynaecological Cancers Serum Tumour Markers: CA125,CEA, CA19.9. bhcg, Inhibin, Oetrogen - in presentation and follow- up. Imaging Techniques and their use: CT /MRI Scans, Ultrasound and Radiation effects Histopathology : Tumour Types and relevance of tumour grade, lymph vascular space invasion Cytology: basic utility of cytology in cervical smear and fluids The role of investigations in follow-up and relapse. In depth knowledge of clinical presentation, diagnostic tests, and appropriate management of Gynaecological Cancers. Vulval Cancer: Clinical presentation Disease Staging [FIGO] Importance of disease size, site, and histopathology. Imaging requirements role of CT, MRI, CXR Surgical and non-surgical therapies Disease relapse: patterns of relapse, investigations

9 Cervical Cancer: Clinical presentation, Disease staging, [FIGO] Imaging requirements role of CT, MRI, IVU, CXR Role of surgery Fertility Preserving Surgery Chemo-radiotherapy Disease relapse: patterns of relapse, investigations Endometrial Cancer: Clinical presentation, Disease Staging [FIGO] Role of ultrasound and risk of malignancy. Role of CT, MRI, CXR Identification of low and high risk patients according to histopathology Triaging patients according to ultrasound PMB clinic and their function Disease relapse: patterns of relapse, investigations Ovarian Cancer: Clinical presentation- role of ultrasound, CT imaging, MRI,CXR Disease Staging [FIGO] Trans-vaginal Scan features of malignancy on Scan, Serum blood test: CA125, CEA, CA19.9, bhcg, AFP Risk of Malignancy Index Disease relapse: patterns of relapse, investigations Trophoblast Disease: Clinical Presentation molar pregnancy, partial molar pregnancy, choriocarinoma, risk factors. bhcg and follow up, use of contraceptive, timing of pregnancy Specialist Centres Disease relapse: patterns of relapse, investigations

10 Good knowledge of options available for treating gynaecological cancers, and palliation of symptoms. The role of surgical and non-surgical interventions, complications, sequelae. Fertility Preservation procedures available in Cervical Cancer: trachalectomy, pelvic lymphadenectomy, pregnancy complications and outcomes. Fertility Preservation in Ovarian Cancer: Chemotherapy in Ovarian Cancer: platinum based therapy, iv and ip treatments, second line therapies, disease response rates. Chemo-radiotherapy in cervical cancer and vulval cancer The role of Radiotherapy in Endometrial cancer: in primary and adjuvant settings Palliative Care: Introduction of service, Do Not Resusitate Criteria, methods of analgesia, Radiotherapy/Chemotherapy in palliation. Role of surgery, tumour excision, bowel diversionary procedure, paracenthesis, pleuridesis. Rarer Gynaecological Cancers: Vaginal Cancer, risk, presentation, basic management. Fallopian tube Carcinomas: Clinical Presentation, basic management. Genetic Risk/Screening: Principles of screening, BRCA1and 2gene, evaluation of risk from family history. HNPCC and risk of ovarian and endometrial cancer. Implications of genetic screening. Understanding of management issues in the provision of Gynaecological Cancer Unit Services Staffing Facilities and equipment Referral patterns and triage Managing a rapid access clinic Patient pathways and time constraints External support Training Clinical protocols, Risk management Audit and research

Advanced Training Skills Module August Vulval Disease

Advanced Training Skills Module August Vulval Disease Introduction Vulval Disease This module is designed to provide training in all aspects of vulval disease. Successful completion of the ATSM will equip an individual to develop this aspect of care in their

More information

Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer

Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer NICaN Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer Timed schedules to enable the proactive management of the patient from point of receipt of referral to first definitive treatment

More information

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Vagina. 1. Introduction. 1.1 General Information and Aetiology Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.

More information

Guideline for the Follow-up of Patients with Gynaecological Malignancies

Guideline for the Follow-up of Patients with Gynaecological Malignancies Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated

More information

Guideline for the Management of Vulval Cancer

Guideline for the Management of Vulval Cancer Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11

More information

Training in Gynaecological Oncology LOG BOOK

Training in Gynaecological Oncology LOG BOOK Training in Gynaecological Oncology LOG BOOK Approved by The European Board and College of Obstetrics and Gynaecology (EBCOG) and the European Society of Gynaecological Oncology (ESGO) TO BE COMPLETED

More information

Core Module 13: Gynaecological Problems

Core Module 13: Gynaecological Problems Core Module 13: Gynaecological Problems Learning outcomes: To understand and demonstrate appropriate knowledge, skills and attitudes in relation to common gynaecological disorders To understand paediatric

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND

More information

Cervical cancer presentation

Cervical cancer presentation Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000

More information

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma

More information

Vaginal intraepithelial neoplasia

Vaginal intraepithelial neoplasia Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network Gynaecological Cancer Managed Clinical Network Audit Report Ovarian Cancer Quality Performance Indicators Cervical Cancer Quality Performance Indicators Endometrial Cancer Quality Performance Indicators

More information

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT

More information

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,

More information

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1 Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Gynaecological sarcomas Version 1 Background This guidance is to provide direction for the management of patients with sarcomas

More information

Health Board/Region: All-Wales

Health Board/Region: All-Wales Peer Review: Cancer Sub-site: Gynaecology Health Board/Region: All-Wales Cycle: Second Date of review: February 2018 This report describes the findings and themes observed by clinical review panels during

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

Newton Wellesley Hospital 2013

Newton Wellesley Hospital 2013 Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

Aneurin Bevan University Health Board Breast Cancer and Pregnancy Guideline

Aneurin Bevan University Health Board Breast Cancer and Pregnancy Guideline Breast Cancer and Pregnancy Guideline N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed versions of the document. The Intranet should be referred

More information

Gynecology Oncology Rotation

Gynecology Oncology Rotation McGill University Obstetrics and Gynecology Residency Program Goals and Objectives Gynecology Oncology Rotation Overview Goal The primary goal of the resident s Gynecology Oncology rotation of 4 weeks

More information

SUBSPECIALIST TRAINING PROGRAMME

SUBSPECIALIST TRAINING PROGRAMME EUROPEAN BOARD AND COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS (EBCOG) AND EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY (ESGO) SUBSPECIALIST TRAINING PROGRAMME IN GYNAECOLOGICAL ONCOLOGY This Programme

More information

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention 6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology

More information

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 Ovarian cancer: recognition and initial management Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Audit Report Report of the 2010 Clinical Audit Data

Audit Report Report of the 2010 Clinical Audit Data Gynaecological Cancer Managed Clinical Network Audit Report Report of the Clinical Audit Data Nick Reed Consultant Clinical Oncologist MCN Clinical Lead (Joint) Nadeem Siddiqui Consultant Gynaecological

More information

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on? MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion

More information

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April

More information

RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.

RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. AIMS AND OBJECTIVES OF THE NEXT ½ HOUR. Brief overview of the different types of gynaecological cancers

More information

Staging and Treatment Update for Gynecologic Malignancies

Staging and Treatment Update for Gynecologic Malignancies Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths

More information

MRI in Cervix and Endometrial Cancer

MRI in Cervix and Endometrial Cancer 28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial

More information

Audit Report Report of the 2012 Clinical Audit Data

Audit Report Report of the 2012 Clinical Audit Data Gynaecological Cancer Managed Clinical Network Audit Report Report of the 2012 Clinical Audit Data Nadeem Siddiqui Consultant Gynaecological Oncologist MCN Clinical Lead Kevin Campbell MCN Manager Julie

More information

Structured Training and Assessment: United Kingdom Perspective. Prof Maggie Cruickshank Past President of BSCCP University of Aberdeen Aberdeen UK

Structured Training and Assessment: United Kingdom Perspective. Prof Maggie Cruickshank Past President of BSCCP University of Aberdeen Aberdeen UK Structured Training and Assessment: United Kingdom Perspective Prof Maggie Cruickshank Past President of BSCCP University of Aberdeen Aberdeen UK Disclosures No financial relationships or conflict of interest

More information

Challenges and successes with cervical cancer early detection and treatment in Kenya

Challenges and successes with cervical cancer early detection and treatment in Kenya Challenges and successes with cervical cancer early detection and treatment in Kenya Omenge Orangó MD Chair, Department of Reproductive Health and Divisional Head of Gynecologic Oncology, Moi University

More information

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion 5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

Core Module 7: Surgical Procedures

Core Module 7: Surgical Procedures Core Module 7: Surgical Procedures Learning outcomes: To understand and demonstrate appropriate knowledge, skills and attitudes in relation to surgical procedures Knowledge criteria GMP Clinical competency

More information

Prevention, Diagnosis and Treatment of Gynecologic Cancers

Prevention, Diagnosis and Treatment of Gynecologic Cancers Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer

More information

INFORMATION GUIDE FOR GYNAECOLOGICAL CANCER

INFORMATION GUIDE FOR GYNAECOLOGICAL CANCER INFORMATION GUIDE FOR GYNAECOLOGICAL CANCER 1 The Australia New Zealand Gynaecological Oncology Group is Australia s peak national research organisation. It raises awareness and funds for gynaecological

More information

PATIENT INFORMATION. about CERVICAL CANCER

PATIENT INFORMATION. about CERVICAL CANCER PATIENT INFORMATION about CERVICAL CANCER What is Cervical Cancer? The cervix is the lower part of the uterus (womb) connecting the body of the uterus to the vagina (birth canal). Cancer of the cervix

More information

Endometrial (womb) cancer

Endometrial (womb) cancer Endometrial (womb) cancer Gynaecology Oncology Patient Information Leaflet Introduction This information is for women who have been diagnosed with endometrial cancer. Hopefully it will answer some of your

More information

Index. B Bilateral salpingo-oophorectomy (BSO), 69

Index. B Bilateral salpingo-oophorectomy (BSO), 69 A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell

More information

Surveillance report Published: 17 March 2016 nice.org.uk

Surveillance report Published: 17 March 2016 nice.org.uk Surveillance report 2016 Ovarian Cancer (2011) NICE guideline CG122 Surveillance report Published: 17 March 2016 nice.org.uk NICE 2016. All rights reserved. Contents Surveillance decision... 3 Reason for

More information

RANZCOG Advanced Training Modules

RANZCOG Advanced Training Modules RANZCOG Advanced Training Modules Generalist Obstetrics ATM and Generalist Gynaecology ATM The Generalist ATMs in each of Obstetrics and Gynaecology provide a framework for trainees to consolidate and

More information

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date

More information

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

More information

What is endometrial cancer?

What is endometrial cancer? Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Clinical Pathological Conference. Malignant Melanoma of the Vulva Clinical Pathological Conference Malignant Melanoma of the Vulva History F/48 Chinese Married Para 1 Presented in September 2004 Vulval mass for 2 months Associated with watery and blood stained discharge

More information

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary North of Scotland Cancer Network Cancer of the Ovary Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by NOSCAN Gynaecology Cancer

More information

LCA Gynaecological Cancer Clinical Guidelines

LCA Gynaecological Cancer Clinical Guidelines LCA Gynaecological Cancer Clinical Guidelines July 2014 LCA GYNAECOLOGICAL CANCER CLINICAL GUIDELINES Contents Introduction... 5 Executive summary... 6 1 The Structure of Gynaecology Oncology Services...

More information

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE DR GARY FENTIMAN, CLINICAL LEADER COLPOSCOPY, N C S P TAKE-HOME LESSONS Vaccination is Primary Prevention for Cervical Cancer Women

More information

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with

More information

Ovarian cancer. Quick reference guide. Issue date: April The recognition and initial management of ovarian cancer

Ovarian cancer. Quick reference guide. Issue date: April The recognition and initial management of ovarian cancer Issue date: April 2011 Ovarian cancer The recognition and initial management of ovarian cancer Developed by the National Collaborating Centre for Cancer About this booklet This is aquick reference guide

More information

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Gynecologic Malignancies. Kristen D Starbuck 4/20/18 Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial

More information

Ovarian Cancer Quality Performance Indicators

Ovarian Cancer Quality Performance Indicators Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official

More information

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: SURGICAL ONCOLOGY 5-May-2013 DEVELOPED BY: Bruce

More information

Epithelial Ovarian Cancer

Epithelial Ovarian Cancer Epithelial Ovarian Cancer GYNE/ONC Practice Guideline Dr. Alex Hammond Dr. Ian Kerr Dr. Akira Sugimoto Dr. Stephen Welch Kay Faroni Christine Gawlik Kerri Thornton Approval Date: This guideline is a statement

More information

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Goal The goal of the Breast Surgery rotation is to develop the knowledge, skills and attitudes necessary to evaluate,

More information

Cytology Update M Laing QEUH

Cytology Update M Laing QEUH Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME

More information

2- Aim of training To improve the care of patients with gynaecological malignancies in collaborations with other care providers.

2- Aim of training To improve the care of patients with gynaecological malignancies in collaborations with other care providers. 1 Training in Gynaecological Oncology CURRICULUM and LOG BOOK Approved by The European Board and College of Obstetrics and Gynaecology (EBCOG) and the European Society of Gynaecological Oncology (ESGO)

More information

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecology Cancer Red Flags Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecological Cancers Endometrial Cancer Ovarian Cancer Cervical

More information

Work Programme/Service Delivery Plan 2010/2013

Work Programme/Service Delivery Plan 2010/2013 Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May

More information

ANNUAL CLINICAL REPORT 2016: GYNAECOLOGICAL ONCOLOGY COLPOSCOPY. Lois Eva Clinical Director

ANNUAL CLINICAL REPORT 2016: GYNAECOLOGICAL ONCOLOGY COLPOSCOPY. Lois Eva Clinical Director ANNUAL CLINICAL REPORT 2016: GYNAECOLOGICAL ONCOLOGY COLPOSCOPY Lois Eva Clinical Director Colposcopy 2016 2067 Colposcopies, 65% initial assessments 40% of referrals are for women

More information

One of the commonest gynecological cancers,especially in white Americans.

One of the commonest gynecological cancers,especially in white Americans. Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in

More information

Cervical Cancer Guidelines L and SC Network July Introduction:

Cervical Cancer Guidelines L and SC Network July Introduction: Cervical Cancer Guidelines L and SC Network July 2018 Introduction: There was a total number of 442 cases of cervix cancer diagnosed in Lancashire and South Cumbria Cancer Network in the period 2005 2009

More information

Endometrial Cancer. Incidence. Types 3/25/2019

Endometrial Cancer. Incidence. Types 3/25/2019 Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy

More information

Gynecological Cancers in Primary Care

Gynecological Cancers in Primary Care Gynecological Cancers in Primary Care Nora M. Lersch MSN CRNP AOCNP Division of Gynecological Oncology Objectives Identify the incidence of ovarian, cervical, vulvar and endometrial cancer Identify common

More information

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Why do we need 2 week wait? Early/timely diagnosis of cancer Possibly less invasive treatment and

More information

REFERRAL GUIDELINES: GYNAECOLOGY

REFERRAL GUIDELINES: GYNAECOLOGY All patients referred to specialist clinics are assigned to a priority category based on their clinical need and related psychosocial factors. The examples given are indicative only and the clinician reviewing

More information

Cervical Cancer - Suspected

Cervical Cancer - Suspected Cervical Cancer - Suspected Presentation for patients Asymptomatic presentation Symptomatic presentation History and examination Consider differential diagnoses RED FLAG! Cervix appears normal after examination

More information

Cancer of Unknown Primary (CUP)

Cancer of Unknown Primary (CUP) Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and

More information

CERVICAL CANCER FACTSHEET. What is cervical cancer?

CERVICAL CANCER FACTSHEET. What is cervical cancer? CERVICAL CANCER FACTSHEET What is cervical cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at a grassroots level. Take-up

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf

More information

Vulvar cancer: Know what to expect

Vulvar cancer: Know what to expect Vulvar cancer: Know what to expect For women with vulvar cancer What is the vulva? The vulva is the external (outside) part of the female genitals. The vulva includes the outer and inner lip, the clitoris,

More information

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast and Ovarian Cancer is a genetic condition which

More information

Gynaecological Cancer and Cervical Screening. Dr Priya Agrawal Obstetrics & Gynaecology SpR/ACF

Gynaecological Cancer and Cervical Screening. Dr Priya Agrawal Obstetrics & Gynaecology SpR/ACF Gynaecological Cancer and Cervical Screening Dr Priya Agrawal Obstetrics & Gynaecology SpR/ACF What will be covered Understand the epidemiology, aetiology, diagnosis, management and prognosis of gynaecological

More information

DEPARTMENT OF ONCOLOGY ELECTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:

More information

Case Scenario 1. History

Case Scenario 1. History History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family

More information

Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.

Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. Cervical Cancer Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. The cervix is the lower, narrow end of the uterus (the hollow, pear-shaped organ where

More information

COMPETENCY BASED FRAMEWORK FOR SCIENTIST REPORTING STAGE D OF HISTOPATHOLOGY REPORTING TRAINING

COMPETENCY BASED FRAMEWORK FOR SCIENTIST REPORTING STAGE D OF HISTOPATHOLOGY REPORTING TRAINING COMPETENCY BASED FRAMEWORK FOR SCIENTIST REPORTING STAGE D OF HISTOPATHOLOGY REPORTING TRAINING COMPETENCY BASED FRAMEWORK FOR SCIENTIST REPORTING 1. BACKGROUND Individuals who are successful in the final

More information

Epithelial ovarian cancer

Epithelial ovarian cancer Scottish Intercollegiate Guidelines Net work 75 Epithelial ovarian cancer A na tion al clinical guideline 1 Introduction 1 2 Screening and the role of prophylactic oophorectomy 3 3 Diagnosis 6 4 Surgical

More information

Guidelines for the Management of Bladder Cancer

Guidelines for the Management of Bladder Cancer Guidelines for the Management of Bladder Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Version 3 and 4 Sections 5.2 and 8 updated Page 1 of 9 1. Scope of

More information

BRCA mutation carrier patient: How to manage?

BRCA mutation carrier patient: How to manage? BRCA mutation carrier patient: How to manage? Clinical Case Presentation Katarzyna Sosińska-Mielcarek Department of Oncology and Radiotherapy University Clinical Center Gdansk, Poland esmo.org DISCLOSURE

More information

SCAN Gynaecological Group. Clinical Management Protocols vulval cancer

SCAN Gynaecological Group. Clinical Management Protocols vulval cancer SE Scotland Cancer Network SCAN Gynaecological Group Clinical Management Protocols vulval cancer 2009 www.scan.scot.nhs.uk August 2001 updated annually, most recently INTRODUCTION The South East Scotland

More information

Algorithms for management of Cervical cancer

Algorithms for management of Cervical cancer Algithms f management of Cervical cancer Algithms f management of cervical cancer are based on existing protocols and guidelines within the ESGO comunity and prepared by ESGO Educational Committe as a

More information

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital: May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx

More information

Cervical Cancer: 2018 FIGO Staging

Cervical Cancer: 2018 FIGO Staging Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford

More information

Gynecological Cancers

Gynecological Cancers Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and

More information

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1 What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical

More information

Triage of Ovarian Masses. Andreas Obermair Brisbane

Triage of Ovarian Masses. Andreas Obermair Brisbane Triage of Ovarian Masses Andreas Obermair Brisbane Why Triage? In ovarian cancer, best outcomes for patients can be achieved when patients are treated in tertiary centres by a multidisciplinary team led

More information

Referral and Management Guidelines for Gynaecological Cancers within North Trent

Referral and Management Guidelines for Gynaecological Cancers within North Trent North Trent Cancer Network Referral and Management Guidelines for Gynaecological Cancers within North Trent Final Version 3.0 August 2011 Review date : June 2013 Produced by the North Trent Cancer Network

More information

The European Board of Urology

The European Board of Urology Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal

More information

Janjira Petsuksiri, M.D

Janjira Petsuksiri, M.D GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors

More information

Gynecologic Oncology Level: PGY-4

Gynecologic Oncology Level: PGY-4 Gynecologic Oncology Level: PGY-4 Service: Oncology Length of Rotation: 4 months Supervision: PGY-4 Resident Oncology Faculty All resident activity is directly supervised by the attending physician assigned

More information

Pregnancy in the middle of adjuvant treatment of Her2 positive breast cancer

Pregnancy in the middle of adjuvant treatment of Her2 positive breast cancer ESMO Preceptorship Programme ESMO Preceptorship ADOLESCENTS & YOUNG ADULTS MALIGNANCIES Lugano, Switzerland 11-12 May 2018 Petra Vuković, University Hospital for Tumors, University Hospital Center Sestre

More information

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy

More information

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to: 1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications

More information